Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sanofi - American Depositary Shares (NQ:SNY)

47.83 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sanofi - American Depositary Shares

< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
40 41 Next >
News headline image
Apple, Meta, Pfizer Among Key Companies Reporting In The Week Ahead, As Earning Picks Up Pace ↗
Big tech earnings will flow in thick and fast in the upcoming week, providing more clarity on how supply chain disruptions and the macroeconomic malaise have impacted these companies. 
Via Benzinga
News headline image
Pasithea's Latest Drug Candidate Could Bring New Hope To ALS Patients Without Effective Treatment Options ↗
Amyotrophic lateral sclerosis (ALS) is a rare but painful and fatal disease that slowly shuts down all voluntary movements in the body, from walking to breathing. 
Via Benzinga
News headline image
Analyzing Sanofi's Short Interest ↗
Sanofi's (NASDAQ:SNY) short percent of float has fallen 14.29% since its last report. The company recently reported that it has 3.00 million shares sold short, which is 0.12% of... 
Via Benzinga
News headline image
Clovis Oncology (CLVS) Stock Pops 7% on Supply Agreement ↗
CLVS stock is rallying 7% after Clovis Oncology made a major deal with NorthStar Medical. Takeover speculation has swirled around Clovis. 
Via InvestorPlace
News headline image
Daily Stock Analysis: Sanofi S.A. ↗
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. It was founded in 1973 and is headquartered in Paris. 
Via Talk Markets
News headline image
Sanofi's Fitusiran Prophylaxis Cuts Bleeds By 61% In Hemophilia Patients ↗
 
Via Benzinga
News headline image
Sanofi Dives After FDA Slaps Its $3.7 Billion Drug With A Hold ↗
The company was testing the drug in multiple sclerosis and myasthenia gravis. 
Via Investor's Business Daily
News headline image
The Daily Biotech Pulse: Sesen Bio Stops Lead Assest Development In US, FDA Approves Eton Pharma's Partial Seizures Drug, Bavarian Nordic Inks Multiple Supply Pact For Monkeypox Vaccine ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Regeneron-Sanofi's Dupixent Hits Primary Goal In Esophagitis Patients Below 11 Years ↗
 
Via Benzinga
News headline image
Sanofi Offloads 17 Products To Neuraxpharm ↗
Sanofi SA (NASDAQ: SNY) has entered a deal to hand over 17 products to central nervous system (CNS) specialist Neuraxpharm for an undisclosed sum.  
Via Benzinga
News headline image
Why Sanofi Shares Are Falling Today ↗
 
Via Benzinga
News headline image
The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
SOBI-Sanofi Partnered Hemophilia Therapy Shows Superior Bleed Protection Than Prior Prophylaxis ↗
 
Via Benzinga
News headline image
Biotech Stocks To Watch And Pharma Industry News ↗
Track the latest trends and leading stocks in the biotech and pharmaceutical industries. 
Via Investor's Business Daily
News headline image
This New York-Based Digital Therapeutics Company Looks To Disrupt a $475 Billion Market ↗
As the global coronavirus pandemic forced people to keep their distance from one another, there has been an increase in the adoption of digital health solutions among healthcare professionals and... 
Via Benzinga
News headline image
INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Sanofi with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
The Daily Biotech Pulse: AstraZeneca Goes Shopping, TYME Technologies & Syros Pharma Merger, FDA Clears Vertex Pharma's Stem Cell-Based Diabetes Therapy Study ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Sanofi with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
How Is The Market Feeling About Sanofi? ↗
Sanofi's (NASDAQ:SNY) short percent of float has fallen 22.22% since its last report. The company recently reported that it has 3.47 million shares sold short, which is 0.14% of... 
Via Benzinga
News headline image
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates ↗
The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled during the month, thanks to a reversal in broader market sentiment. 
Via Benzinga
News headline image
The Daily Biotech Pulse: Pfizer/BioNTech Ink New COVID-19 Vaccine Supply Pact, Sanofi Hit By FDA Clinical Hold, Angion Biomedica Halts Second Kidney Disease Trial ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Pfizer, Moderna Analysts Respond To FDA COVID Booster Ruling: 'Revenues Will Decline' ↗
The Food and Drug Administration’s panel of independent vaccine experts recently voted 19 to 2 to recommend a new batch of COVID-19 booster shots targeting the omicron variant this fall. The news,... 
Via Benzinga
News headline image
Sanofi Lowers Out-Of-Pocket Insulin Cost For Uninsured Patients ↗
 
Via Benzinga
News headline image
Finally An Omicron-Blocking Shot? Sanofi, GSK Say Yes ↗
The companies' shot was more than 93% effective in previously infected people. 
Via Investor's Business Daily
News headline image
Benzinga Before The Bell: Gun Safety Bill. Bill Gates's North Dakota Outrage, Sanofi-GSK's Covid-19 Vaccine's Omicron Efficacy And Other Top Financial Stories Friday, June 24 ↗
Reuters 
Via Benzinga
News headline image
Sanofi-GSK's Beta-Containing COVID-19 Vaccine Shows Efficacy Against Omicron ↗
 
Via Benzinga
News headline image
This Pharmaceutical Company Is Moving Beyond CBD ↗
The applications for cannabidiol (CBD) and cannabinoid-based therapeutics are many. Many novel treatments have been, and are continuing to be, discovered using these compounds. The industry is huge... 
Via Benzinga
News headline image
Jupiter Wellness Believes Its Latest Strategic Acquisition Could Be A Significant Boon To Compete In The Medical Cannabis Industry ↗
Companies like Tilray Inc. (NASDAQ: TLRY) and Cara Therapeutics Inc. 
Via Benzinga
News headline image
Clovis Oncology (CLVS) Stock Gains 20% on Tumor Trials, Buyout Hopes ↗
Today has been another strong one for investors in Clovis Oncology and CLVS stock, with this company surging another 20% in today's session. 
Via InvestorPlace
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
40 41 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.